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Abstract
The aim of the study was to analyze genotype I hepatitis A virus (HAV) 59 nontranslated region (NTR) sequences from a
recent outbreak in South Korea and compare them with reported sequences from Japan. We collected a total of 54 acute
hepatitis A patients’ sera from HAV genotype I [27 severe disease (prothrombin time INR$1.50) and 27 mild hepatitis
(prothrombin time INR ,1.00)], performed nested RT-PCR of 59 NTR of HAV directly sequenced from PCR products
(,300 bp), and compared them with each other. We could detect HAV 59NTR sequences in 19 of the 54 (35.1%) cases
[12 of 27 severe cases (44.4%) and 7 of 27 self-limited cases (25.9%)], all of which were subgenotype IA. Sequence analysis
revealed that sequences of severe disease had 93.6%–99.0% homology and of self-limited disease 94.3%–98.6% homology,
compared to subgenotype IA HAV GBM wild-type IA sequence. In this study, confirmation of the 59NTR sequence
differences between severe disease and mild disease was not carried out. Comparison with Japanese HAV A10 revealed
222C to G or T substitution in 8/12 cases of severe disease and
222C to G or T and
392G to A substitutions in 5/7 and
4/7 cases of mild disease, respectively, although the nucleotide sequences in this study showed high homology
(93.6%–100%). In conclusion, HAV 59NTR subgenotype IA from Korea had relatively high homology to Japanese sequences
previously reported from Japan, and this region would be considered one of the antiviral targets. Further studies will be
needed.
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Introduction
Although hepatitis A vaccination is highly effective, providing
herd protection and decreasing mortality and morbidity related to
the hepatitis A virus (HAV) [1–3], HAV is still a common cause of
hepatitis reportedly leading to occasional lethal acute liver failure
in many countries of the world [4–7]. Recently, a rise in the
frequency of hepatitis A outbreaks was observed in South Korea,
which lies adjacent to Japan, while the number of adult hepatitis A
cases in Japan has been progressively decreasing during the last
several years. There is a concern regarding a possible HAV
epidemic in Japan in the near future, as universal vaccination
against hepatitis A is not performed in this country.
HAV is a member of the genus Hepatovirus in the Picornaviridae
family, and has a positive-sense single-stranded RNA genome
approximately 7.5 kb in length [8]. The genome codes a large
open reading frame (ORF), which is flanked by 59 nontranslated
region (59NTR) and 39NTR. The downstream part of 59NTR
represents the internal ribosomal entry site (IRES), which mediates
cap-independent translation initiation and is important for HAV
replication [9,10]. 59NTR of HAV is also known as one of the
most highly conserved in the HAV genome sequences, making this
region one of the likely candidates for antiviral targets [9,11]. It
was reported that nucleotide variations in the central portion of
59NTR of HAV may influence the severity of hepatitis A [12].
Human HAV strains can be grouped into four genotypes (I, II,
III and IV) and unique simian strains belong to three additional
genotypes (IV, V and VI). Between each of these genotypes, the
nucleotide sequence varies by 15–20% of the base positions in the
P1 region [13]. Genotype I is the most abundant type worldwide,
and genotype IA in particular has been reported from North
America, Korea, China, Japan and Thailand [14].
The aim of this study is to characterize the recent HAV
genotype I 59NTR sequences in Korea, to compare them with
those reported from Japan and to clarify this region as a target
candidate for anti-HAV drugs.
Materials and Methods
Patients
Fifty-four patients infected with HAV subgenotypes IA and IB
were included in this study. Serum samples were collected at four
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Korea. Our study was approved by the Seoul National University
Bundang Hospital Institutional Review Board (IRB), and we
obtained written informed consent from every patient enrolled
during Sep 2008 to Aug 2008. We collected serum or plasma
samples immediately after hospital admission, and they were
stored at 270uC. The 54 patients comprised 27 with severe
disease, defined as prolonged prothrombin time [international
normalized ratio (INR) . or =1.5] and 27 with mild disease: self-
limited acute hepatitis in this study (Table S1A & S1B).
Primers for PCR and Direct Sequencing
For amplification of HAV sequences and bidirectional direct
sequencing of the amplified segments, we prepared several primers
for PCR and sequencing as previously described [12]. These
primers were prepared with the sequence reported by Cohen et al
[8].
Detection of Hepatitis A Virus RNA in Serum
RNA was extracted from sera using the acid guanidinium-
phenol-chloroform method. Reverse transcription was performed
with HAV genome specific antisense primer (59-AGTACCTCA-
GAGGCAAACAC-39) as previously described [12].
In the first round PCR, 1 mlo f2 0ml of the cDNA solution was
used. The first round PCR was performed with 50 ml of reaction
mixture containing 25 pmol of outer antisense primer (59-
AGTACCTCAGAGGCAAACAC-39) and sense primer (59-
TCTTGGAAGTCCATGGTGAG-39), 200 mM of each dNTP,
50 mM KCl, 10 mM Tris HCL (pH 8.3), 1.5 mM MgCl2,
0.001% gelatin, and 2.5 units of Ex Taq polymerase (Takara
Bio Inc., Ohtsu, Shiga, Japan). Amplification conditions consisted
of 35 cycles of 95uC for one minute, 50uC for one minute, and
72uC for one minute, and 1 ml of the first round product was used
for the second round of PCR with the same PCR mixture, except
1.0 mM of inner sense primer (59-GGGACTTGATACCT-
CACCGC-39) and antisense primer (59-CCACATAAGGCCC-
CAAAGAA-39) were used. Amplification conditions for the second
round were the same as those for the first round. The second-
round PCR products (6 ml) were analyzed by 8% polyacrylamide
gel electrophoresis, stained with SyBr green (Takara), and
visualized by UV transillumination. In all experiments, the
negative samples showed negative results for HAV RNA. HAV
genotypes were determined by previously described methods
based on the VP1-P2A region [14].
Direct Sequencing of HAV cDNA Fragments
To prepare the sequence template (nucleotides 75-638 of
59NTR of HAV), PCR products were treated with ExoSAP-ITR
(Affymetrix, Inc., Santa Clara, CA), and then sequenced using a
BigDye(R) Terminator v3.1 Cycle Sequencing Kit (Life Technol-
ogies, Tokyo, Japan). Sequences were analyzed using Applied
Biosystems 3730xl (Life Technologies).
Nucleotide Sequence Accession Numbers
The nucleotide sequence data reported in this article will appear
in GenBank nucleotide sequence databases with accession
numbers AB571027 to AB571045.
Phylogenetic Analysis
To examine the heterogeneity of the viral sequences obtained, a
phylogenetic tree was constructed using the neighbor joining
methods. To confirm the reliability of the phylogenetic tree,
bootstrap resampling tests were performed 10,000 times. These
analyses were conducted with the Genetyx-WIN program, version
10 (Software Development, Tokyo, Japan).
Statistical analysis
Differences in proportions among the groups were compared by
Fisher’s exact probability test, Student’s t test and Welch’s t test.
Results
Clinical Features of Patients with Acute Hepatitis A
Genotype 1 in Korea
Characteristics of these patients at admission are summarized in
Table S1. There were no differences in age and gender ratio
between the severe and mild disease groups. Mean age of the
severe and mild disease groups was 32.166.1 and 32.665.8 years,
respectively. Male gender was dominant in both groups (male/
female: 19/8 and 18/9 in the severe and mild disease groups,
respectively). Almost all patients of both groups were subgenotype
IA, with only two and one being subgenotype IB in the severe and
mild disease groups, respectively.
Sequence Analysis of Korean Isolates
Although the VP1/2A region could be detected in the same
serum or stool samples of the same patients, we could detect HAV
59NTR sequences in 19 of the 54 (35.1%) cases [12 of 27 severe
cases (44.4%) and 7 of 27 self-limited cases (25.9%)] by reverse-
transcription-nested PCR. All these sequences were subgenotype
IA. Then we performed further sequence analysis in these 19
patients by the methods of Fujiwara et al [12]. Japanese studies
showed that fewer nucleotide variations were found between
nucleotides 200 and 500 of 59NTR in cases of fulminant hepatitis
and severe acute hepatitis than in cases of self-limited acute
hepatitis [12]. We thusly performed sequence analysis of the
region between nucleotides 200 and 500.
Sequences between nucleotides 200 and 500 were then
compared with the wild-type HAV GBM/WT RNA (X75215)
[15]. The nucleotide sequence identities of 59NTR from severe
and mild cases ranged from 93.6% to 99.0% and from 94.3% to
98.6%, respectively, compared with wild-type HAV GBM
sequence. The distribution of nucleotide variations is shown in
Table S2A & S2B. Sequences from cases of severe and mild




464T were found in one case each of
the mild disease group (Table S2B). On the other hand,
227deletion of nucleotide and
382A, respectively, were found in
two and one cases of the severe disease group (Table S2A). The
number of nucleotide substitutions is shown in Figure 1A & 1B.
The average number of substitutions between nucleotides 200 and
500 was 10.8 (6.8) [mean (SD)] per case in severe disease and 6.8
(4.5) in mild disease. Differences between severe and mild cases
were not statistically significant. We could not construct a
phylogenetic tree using these sequences (data not shown).
Comparison to Japanese HAV Sequences Reported from
1984 to 1999
59NTR of HAV possesses a secondary structure including stems
and loops, functions as an IRES, and plays an important role in
translation and replication of this virus [9,16]. There are six
domains in IRES, which is located between nucleotides 151 and
734. Portions of domains III and IV are present between
nucleotides 200 and 500. Domain III is located between
nucleotides 99 and 323, and domain IV is located between
nucleotides 324 and 586. The region between nucleotides 203 and
HAV 59 NTR Sequence Variation in Korea
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with the HAV sequences from Japan reported by Fujiwara et al.
[12], we compared the sequences from nucleotides 200 to 500 with
A10 (AB045328) from Japan [12]. The nucleotide sequence
identities of 59NTR from severe and mild disease groups ranged
from 94.3% to 99.6% and from 93.6% to 100%, respectively,
compared with the HAV A10 sequence [12] (Table S3A & S3B).
In the Korean group, we found
222C to G or T substitution in 8/
12 cases of severe disease and
222C to G or T and
392Gt oA
substitutions in 5/7 and 4/7 cases of mild disease, respectively.
Figure 1. Disease severity and nucleotide substitutions in HAV IRES when compared with HAV GBM. (A) Number of nucleotide
substitutions between nucleotides 200 and 500. Nucleotide sequences were compared with HAV GBM/WT RNA (X75215) [15]. Bars represent mean
(SD). Severe, severe disease; Mild, mild disease. (B) Distribution of nucleotide substitutions between nucleotides 200 and 500 of the 59 non-translated
region. Bars indicate the percentage of cases with substitutions at each nucleotide position.
doi:10.1371/journal.pone.0015139.g001
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2B, with the average number between nucleotides 200 and 500
being 9.7 (8.2) [mean (SD)] per case in severe disease and 5.4 (5.2)
in mild disease. Again, differences between severe and mild cases
were not statistically significant.
Discussion
The number of adult hepatitis A cases has been progressively
increasing during the last several years in Korea [6,14]. In Japan,
on the other hand, the number of patients with sporadic type A
Figure 2. Disease severity and nucleotide substitutions in HAV IRES when compared with HAV A10. (A) Number of nucleotide
substitutions between nucleotides 200 and 500 Nucleotide sequences were compared with A10 (AB045328) from Japan [12]. Bars represent mean
(SD). Severe, severe disease; Mild, mild disease. (B) Distribution of nucleotide substitutions between nucleotides 200 and 500 of the 59 non-translated
region. Bars indicate the percentage of cases with substitutions at each nucleotide position.
doi:10.1371/journal.pone.0015139.g002
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1999 inclusive, 763, 381, 491, 502, 303, 139, 170, 320 and 157
hepatitis A cases were reported to the Infectious Disease
Surveillance Center, National Institute of Infectious Diseases,
Tokyo, Japan (www.nih.go.jp). Japan lies adjacent to Korea,
separated by the Sea of Japan. The two countries have some
cultural similarities. In Japan, there is no universal vaccination
program against hepatitis A and hepatitis B. These circumstances
have raised concerns about a possible HAV epidemic in Japan.
We then analyzed HAV genome sequences from Korea and
compared them with the reported sequences from Japan over the
past several years.
In the present study, as most of the HAV strains belonged to
subgenotype IA in Korea [14], we chose only genotype I patients
for analysis. Among 54 HAV IgM positive sera, 35.1% (n=19)
were positive for HAV RNA by nested RT-PCR for 59NTR. All
these strains belonged to subgenotype IA. We tried to perform
phylogenetic tree analysis, but these 19 strains formed a single
cluster to which almost all Japanese sequences reported by
Fujiwara et al [12] belonged (data not shown). Fujiwara et al [12]
found an association between the severity of hepatitis A and
nucleotide variations in 59NTR of Japanese HAV RNA. In the
present study, we did not confirm 59NTR sequence differences
between severe disease and mild disease.
The age of HAV sequence-analyzed patients in the present
study was 30.565.9 and 31.465.0 years, respectively, in severe
and mild diseases. The gender of HAV sequence-analyzed patients
was male-dominant (male/female: 8/4 and 6/1 in the severe
disease and mild disease groups, respectively). In the study by
Fujiwara et al [12], the patients were also male-dominant, but
their age with fulminant hepatitis and severe acute hepatitis
(43.1614.4 year, P=0.010 and 41.6612.6, P=0.010, respective-
ly) was significantly higher than the age of severe-disease patients.
On the other hand, the age of their patients with self-limited acute
hepatitis was similar to that of our mild-disease patients. We
defined patients with prothrombin time INR $1.50 as severe
hepatitis in this study, whereas Fujiwara et al [12] defined patients
with prothrombin time of less than 40% as severe hepatitis with
(fulminant hepatitis) or without encephalopathy (severe acute
hepatitis).
In Japan, similar to the situation in Korea [6], young adults
seem not to have protective antibody against HAV, and so it
appears that hepatitis A cases can be expected to increase in the
near future.
A previous study showed that the 59 border of IRES is located
between nucleotides 151 and 257, while the 39 border extends to
the 39 end of 59NTR, between nucleotide 695 and the first
initiation codon at 735 [17].
222C to G or T substitution was
located on the loop structure at domain IIIa of HAV IRES. A
previous Japanese study showed that nucleotide 225 substitutions
occurred in 80% of the sequences around nucleotide position 222
[12].
392G to A substitution located at domain IV of HAV IRES
was observed in 64.2% (9/14) of the Korean HAV sequences.
Fujiwara et al [12] also reported that substitutions at nucleotide
391 were seen in 32% of Japanese HAV patients. It is possible that
these substitutions were non-specific mutations.
In conclusion, HAV 59NTR subgenotype IA from Korea had
relatively high homology to the Japanese sequences previously
reported, and this region may represent a viable antiviral target. In
Japan, as in Korea, the introduction of childhood vaccination and
catch-up vaccination for adolescents and young adults should be
considered.
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